Alnylam Gets VIP Status as the FDA Slaps Breakthrough Tag on Patisiran Post author:Sam Post published:November 19, 2017 Post category:BioPharma The company is weeks away from completing its rolling NDA for Patisiran. Source: BioSpace You Might Also Like Questions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos March 27, 2017 Boehringer Ingelheim Ditches Phase II Alzheimer's Program February 8, 2018 Kindred Bio To Announce Fourth Quarter And Year-End 2016 Financial Results February 20, 2017
Questions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos March 27, 2017
